Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SMITHKLINE BEECHAM FAMVIR SHINGLES TREATMENT LABELED FOR T.I.D. DOSING

Executive Summary

SMITHKLINE BEECHAM FAMVIR SHINGLES TREATMENT LABELED FOR T.I.D. DOSING, less frequent than labeled dosing of the only other approved shingles (varicella zoster virus) treatment, Burroughs Wellcome's Zovirax (acyclovir), FDA cleared Farnvir (famciclovir) for marketing June 29, Recommended Farnvir dosing is one 500 mg tablet every eight hours for seven days, approved labeling states, while Zovirax labeling recommends 800 mg every four hours five times daily for 7-10 days,
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel